References
- World Health Organization [homepage on the Internet]The global burden of disease: 2004 updateWHO Available from: http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/Accessed June 8, 2015
- Consolidated Report of Hospital Based Cancer Registries 2001–2003National Centre for Disease Informatics and Research National Cancer Registry Programme (Indian Council of Medical Research)2007 Available from: http://www.ncrpindia.org/Reports/HBCR_2001_03.aspxAccessed June 8, 2015
- Consolidated Report of Population Based Cancer Registries 2001–2004National Centre for Disease Informatics and Research National Cancer Registry Programme (Indian Council of Medical Research)2006 Available from: http://www.ncrpindia.org/Reports/PBCR_2001_2004.aspxAccessed June 8, 2015
- PerouCMSorlieTEisonMBMolecular Portraits of human breast tumoursNature2000406679774775210963602
- WolffAHammondMESchwartzJAmerican Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancerJ Clin Oncol200725111814517159189
- CummingsMCChamberRSimpsonPTLakhaniSRMolecular classification of breast cancer. Is it time to pack up our microscopes?Pathology20114311821240058
- DunnwaldLKRossingMALiCIHormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patientsBreast Cancer Res200791R617239243
- RakhaEATanDSFoulkesWDAre triple negative tumours and basal-like breast cancer synonymous?Breast Cancer Res20079640418279542
- OnitiloAAEngelJMGreenleeRTMukeshBNBreast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survivalClin Med Res200971–241319574486
- ChutsteckaZSurvival Disadvantage Seen for TNBCMedscape Medical News2008 Available from: www.medscape.com/viewarticle/554234Accessed April 10, 2015
- ReynoldsSSpotlight: triple –negative breast carcinoma disproportionately affects African American and Hispanic womenNational Cancer Institute Cancer Bulletin2007422 Available from: http://www.cancer.gov/ncicancerbulletin/archive/2007/072407Accessed April 10, 2015
- SharmaMSharmaJDSarmaATriple Negative Breast Cancer in People of North East India: Critical Insights Gained at a Regional Cancer CentreAsian Pac J Cancer Prev201515114507451124969877
- AmbroiseMGhoshMMallikarjunaVSKurianMImmunohistochemical profile of breast cancer patients at a tertiary care hospital in South IndiaAsian Pac J Cancer Prev201112362562921627355
- ZubedaSKaipaPRShaikNAHER-2/neu status: a neglected marker of breast cancer patients in IndiaAsian Pac J Cancer Prev20131442231223523725118
- IwaseHKurebayashiJTsudaHClinicopathological analyses of triple negative breast cancer using surveillance data from the Registration Committee of the Japanese Breast Cancer SocietyBreast Cancer201017211812419466512
- SomaliIUstaogluBYTarhanMOClinicopathologic and demographic evaluation of triple- negative breast cancer patients among a turkish patient population: a single center experienceAsian Pac J Cancer Prev201314106013601724289617
- BauerKRBrownMCressRDPariseCACaggianoVDescriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so called triple-negative phenotype: a population-based study from the California cancer RegistryCancer200710991721127817387718
- CareyLAPerouCMLivsayCARace, breast cancer subtypes, and survival in the Carolina breast cancer studyJAMA2006295212492250216757721
- MaKKChauWWWongCHTriple negative status is a poor prognostic indicator in Chinese women with breast cancer: a ten year reviewAsian Pac J Cancer Prev20121352109211422901178
- LiCYZhangSZhangXBClinicopathological and prognostic characteristics of triple-negative breast cancer (TNBC) in Chinese patients: a retrospective studyAsian Pac J Cancer Prev20131463779378423886182
- PatilVWSinghaiRPatilAVGuravPDTriple-negative (ER, PgR, HER-2/neu) breast cancer in Indian womenBreast Cancer (Dove Med Press)2011391924367172